Literature DB >> 16244897

Evaluation of Fusarium solani hyphae and conidia susceptibility to amphotericin B and itraconazole: study of a clinical case.

A B A Teixeira1, M L Moretti, P Trabasso, A von Nowakonski, F H Aoki, A C Vigorito, M Miyaji, K Nishimura, H Taguchi, A Z Schreiber.   

Abstract

Fusarium species are hyaline moulds belonging to the hyalohyphomycosis group that are usually found in the soil and plants. This organism has emerged as a cause of disseminated invasive disease. The correlation between in vitro value and clinical efficacy is low and many patients remain unresponsive to treatment despite in vitro susceptibility. We determined growth control for Fusarium solani using the BioCell-Tracer system that measures the growth rate of a single fungal hypha, and the effect of different concentrations of amphotericin B and itraconazole. The MIC for these two drugs was also determined by a broth microdilution technique, using RPMI 1640. Different MICs for amphotericin B were obtained by the two different methods. This paper describes a case of infection due to Fusarium solani in an allogeneic bone marrow transplanted patient, the microbiological diagnostic, antifungal susceptibility tests for conidia and hypha and clinical correlation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16244897     DOI: 10.1007/s11046-005-0106-2

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  14 in total

1.  DNA fingerprinting of Fusarium solani isolates related to a cutaneous infection in a sea turtle.

Authors:  G Castellá; J Cano; J Guarro; F J Cabañes
Journal:  Med Mycol       Date:  1999-08       Impact factor: 4.076

2.  Comparison of in vitro antifungal susceptibilities of conidia and hyphae of filamentous fungi.

Authors:  J Guarro; C Llop; C Aguilar; I Pujol
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

3.  Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy.

Authors:  Masahiro Kami; Utako Machida; Katsuko Okuzumi; Tomoko Matsumura; Shin-ichiro Mori Si; Akiko Hori; Takeshi Kashima; Yoshinobu Kanda; Yoichi Takaue; Hisashi Sakamaki; Hisamaru Hirai; Akiko Yoneyama; Yoshitomo Mutou
Journal:  Br J Haematol       Date:  2002-04       Impact factor: 6.998

4.  Standardization of a hyphal inoculum of aspergilli for amphotericin B susceptibility testing.

Authors:  V Bezjak
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

5.  Phaeohyphomycosis caused by Chaetomium globosum in an allogeneic bone marrow transplant recipient.

Authors:  A B A Teixeira; P Trabasso; M L Moretti-Branchini; F H Aoki; A C Vigorito; M Miyaji; Y Mikami; M Takada; A Z Schreiber
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

6.  The internal transcribed spacers and 5.8S rRNA gene show extensive diversity among isolates of the Cryptococcus neoformans species complex.

Authors:  Masakazu Katsu; Sarah Kidd; Akikazu Ando; Maria Luiza Moretti-Branchini; Yuzuru Mikami; Kazuko Nishimura; Wieland Meyer
Journal:  FEMS Yeast Res       Date:  2004-01       Impact factor: 2.796

7.  Amphotericin B: time for a new "gold standard".

Authors:  Luis Ostrosky-Zeichner; Kieren A Marr; John H Rex; Stuart H Cohen
Journal:  Clin Infect Dis       Date:  2003-07-22       Impact factor: 9.079

8.  Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer.

Authors:  Issam Raad; Jeffrey Tarrand; Hend Hanna; Maher Albitar; Erle Janssen; Maha Boktour; Gerald Bodey; Masoud Mardani; Ray Hachem; Dimitrios Kontoyiannis; Estella Whimbey; Kenneth Rolston
Journal:  Infect Control Hosp Epidemiol       Date:  2002-09       Impact factor: 3.254

9.  Identification and phylogeny of ascomycetous yeasts from analysis of nuclear large subunit (26S) ribosomal DNA partial sequences.

Authors:  C P Kurtzman; C J Robnett
Journal:  Antonie Van Leeuwenhoek       Date:  1998-05       Impact factor: 2.271

10.  Fusarium fungaemia in severely neutropenic patients.

Authors:  S T Yildiran; S Kömürcü; M A Saraçli; A Gönlüm; C Beyan; H Gün; A Yalçin
Journal:  Mycoses       Date:  1998-12       Impact factor: 4.377

View more
  3 in total

1.  Standardization of hyphal growth inhibition rate as a means of evaluating Microsporum spp. in vitro susceptibility to terbinafine, griseofulvin, and ciclopiroxolamine.

Authors:  Fernanda Simas Corrêa Biancalana; Luzia Lyra; Maria Luiza Moretti; Katsuhiko Kamei; Angélica Zaninelli Schreiber
Journal:  Mycopathologia       Date:  2011-05-25       Impact factor: 2.574

2.  Disseminated amphotericin-resistant fusariosis in acute leukemia patients: report of two cases.

Authors:  Graziella Hanna Pereira; Derlene Attili de Angelis; Roosecelis Araujo Brasil; Marilena dos Anjos Martins; Dulcilena de Matos Castro e Silva; Maria Walderez Szeszs; Marcia de Souza Carvalho Melhem
Journal:  Mycopathologia       Date:  2012-10-18       Impact factor: 2.574

3.  Fusarium napiforme systemic infection: case report with molecular characterization and antifungal susceptibility tests.

Authors:  Marcela de Souza; Tetsuhiro Matsuzawa; Luzia Lyra; Ariane Fidelis Busso-Lopes; Tohru Gonoi; Angélica Zaninele Schreiber; Katsuhiko Kamei; Maria Luiza Moretti; Plínio Trabasso
Journal:  Springerplus       Date:  2014-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.